Drug Profile
Research programme: steroidal and non-steroidal glucocorticoid receptor agonists - GlaxoSmithKline
Latest Information Update: 19 Apr 2011
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Allergic rhinitis; Inflammation
Most Recent Events
- 18 Apr 2007 Preclinical trials in Allergic rhinitis in United Kingdom (unspecified route)
- 18 Apr 2007 Preclinical trials in Inflammation in United Kingdom (unspecified route)